DarioHealth Corp (NASDAQ:DRIO) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET
Company Participants
Glenn Garmont - LifeSci Advisors
Erez Raphael - CEO & Director
Richard Anderson - President & GM, North America
Conference Call Participants
Charles Rhyee - Cowen and Company
Alexander Nowak - Craig-Hallum
Rahul Rakhit - LifeSci Capital
David Grossman - Stifel, Nicolaus & Company
Benjamin Haynor - Alliance Global Partners
Nathan Weinstein - Aegis Capital Corporation
John Vandermosten - Zacks Small-Cap Research
Operator
Greetings, and welcome to the DarioHealth Corp. Second Quarter 2020 Results Conference Call. [Operator Instructions].
It is now my pleasure to introduce your host, Mr. Glenn Garmont, Investor Relations. Thank you. Please go ahead.
Glenn Garmont
Thank you, Donna. Good morning, everybody, and thank you for joining us today for a discussion of DarioHealth's Second Quarter 2022 Financial Results. Leading the call today will be Erez Raphael, Chief Executive Officer of DarioHealth, and he'll be joined by Rick Anderson, President. After prepared remarks, we'll open the call for Q&A. An audio recording and webcast replay for today's call will also be available online as detailed in the press release invite for this call.
For the benefit of those who may be listening to the replay or archived webcast, this call is being held and recorded on August 15, 2022. This morning, we issued a press release announcing our financial results for the second quarter of 2022. A copy of the release can be found on the Investor Relations page of DarioHealth's website. Actual events or results may differ materially from those projected as a result of changing market trends, reduced demand or the competitive nature of DarioHealth's industry. Such forward-looking statements and implications may involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected.
The forward-looking statements discussed on this call are subject to other risks and uncertainties, including those discussed in the Risk Factors section and elsewhere in the company's 2021 annual report on Form 10-K as well as the second quarter 2022 Form 10-Q, which was filed this morning. Additional information concerning factors that could cause results to differ materially from our forward-looking statements are described in greater detail in the company's press release issued this morning and in the company's other filings with the SEC.
In addition, certain non-GAAP financial measures may be discussed during this call. These non-GAAP measures are used by management to make strategic decisions, forecast future results and evaluate the company's current performance. Management believes the presentation of these non-GAAP financial measures is useful for investors' understanding and assessment of the company's ongoing core operations and prospects for the future. A reconciliation of these non-GAAP measures to the most comparable GAAP measures is included in today's press release regarding our quarterly and year-to-date results.